Modulation of AMPA receptors in spinal motor neurons by the neuroprotective agent riluzole

Journal of Neuroscience Research

Volumn 78, Issue 2, 2004, Pages 200-207

  Albo, Federica ^a   Pieri, Massimo ^b   Zona, Cristina ^a,b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

AMPA receptor; Neuroprotection; Patch clamp

Indexed keywords

1 (4 AMINOPHENYL) 3,4 DIHYDRO 4 METHYL 3 METHYLCARBAMOYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; AMPA RECEPTOR; AMPA RECEPTOR AGONIST; GLUTAMIC ACID; GYKI 5365; KAINIC ACID; KAINIC ACID RECEPTOR; RILUZOLE;

AMPLITUDE MODULATION; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL MEMBRANE CONDUCTANCE; CELL MEMBRANE POTENTIAL; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ELECTRIC CURRENT; ELECTROPHYSIOLOGY; EMBRYO; IMMUNOCYTOCHEMISTRY; MOUSE; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; SPINAL CORD MOTONEURON;

ANIMALS; CELLS, CULTURED; ELECTROPHYSIOLOGY; EXCITATORY AMINO ACID AGONISTS; KAINIC ACID; MICE; MOTOR NEURONS; RECEPTORS, AMPA; RILUZOLE; SPINAL CORD;

EID: 4744371975     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20244     Document Type: Article

References (49)

1. Ballerini L, Bracci E, Nistri A. 1995. Desensitization of AMPA receptors limits the amplitude of EPSPs and the excitability of motoneurons of the rat isolated spinal cord. Eur J Neurosci 7:1229-1234.
2. Benoit E, Escande D. 1991. Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre. Pflugers Arch 419:603-609.
3. Bensimon G, Lacomblez L, Meininger V. 1994. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 330:585-991.
4. Bettler B, Mulle C. 1995. Review: neurotransmitter receptors. II. AMPA and kainate receptors. Neuropharmaclogy 34:123-139.
5. Brorson JR, Manzolillo PA, Gibbons SJ, Miller RJ. 1995. AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity. J Neurosci 15:4515-4524.
6. Bryson HM, Fulton B, Benfield P. 1996. Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis. Drugs 52:549-563.
7. Burnashev N, Monyer H, Seeburg PH, Sakmann B. 1992. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 8:189-198.
8. Cao YJ, Dreixler JC, Coney JJ, Houamed KM. 2002. Modulation of recombinant and native neuronal SK channels by the neuroprotective drug riluzole. Eur J Pharmacol 449:47-54.
9. Carriedo SG, Sensi SL, Yin HZ, Weiss JH. 2000. AMPA exposures induce mitochondrial Ca(2+) overload and ROS generation in spinal motor neurons in vitro. J Neurosci 20:240-250.
10. Carriedo SG, Yin HZ, Weiss JH. 1996. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J Neurosci 16:4069-4079.
11. Centonze D, Calabresi P, Pisani A, Marinelli S, Marfia GA, Bernardi G. 1998. Electrophysiology of the neuroprotective agent riluzole on striatal spiny neurons. Neuropharmacology 37:1063-1070.
12. Couratier P, Hugon J, Sindou P, Vallat JM, Dumas M. 1993. Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors. Lancet 341:265-268.
13. Dai WM, Egebjerg J, Lambert DC. 2001. Characteristics of AMPA receptor-mediated responses of cultured cortical and spinal cord neurons and their correlation to the expression of glutamate receptor subunits, GluR1-4. Br J Pharmacol 132:1859-1875.
14. Debono MW, Le Guern J, Canton T, Doble A, Pradier L. 1993. Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes. Eur J Pharmacol 235:283-289.
15. Dingledine R, Borges K, Bowie D, Traynelis SF. 1999. The glutamate receptor ion channels. Pharmacol Rev 51:7-61.
16. Doble A, 1997. Effects of riluzole on glutamatergic neurotransmission in the mammalian central nervous system and other pharmacological effects. Rev Contemp Pharmacother 8:213-225.
17. Doble A. 1999. The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther 81:163-221.
18. Fleck MW, Bahring R, Patneau DK, Mayer ML. 1996. AMPA receptor heterogeneity in rat hippocampal neurons revealed by differential sensitivity to cyclothiazide. J Neurophysiol 75:2322-2333.
19. Geiger JR, Melcher T, Koh DS, Sakinann B, Seeburg PH, Jonas P, Monyer H. 1995. Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron 15:193-204.
20. Gurney ME, Fleck TJ, Himes CS, Hall ED. 1998. Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis. Neurology 50:62-66.
21. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. 1981. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391:85-100.
22. He Y, Benz A, Fu T, Wang M, Covey DF, Zorumski CF, Mennerick S. 2002. Neuroprotective agent riluzole potentiates postsynaptic GABA(A) receptor function. Neuropharmacology 42:199-209.
23. Hollmann M, Heinemann S. 1994. Cloned glutamate receptors. Annu Rev Neurosci 17:31-108.
24. 2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expression. Neuron 12:1281-1289.
25. Kriz J, Gowing G, Julien JP. 2003. Efficient three-drug cocktail for disease induced by mutant superoxide dismutase. Ann Neurol 53:429-436.
26. Kuo JJ, Schonewille M, Siddique T, Schults AN, Fu R, Bar PR, Anelli R, Heckman CJ, Kroese AB. 2004. Hyperexcitability of cultured spinal motoneurons from presymptomatic ALS mice. J Neurophysiol 91:571-575.
27. Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. 1996. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 347:1425-1431.
28. Lambolez B, Ropert N, Permis D, Russier J, Hestrin S. 1996. Correlation between kinetics and RNA splicing of alpha-amino-3-hydroxy-5-methyhsoxazole-4- propionic acid receptors in neocortical neurons. Proc Natl Acad Sci USA 93:1797-1802.
29. Le Liboux A, Lerebvre P, Le Roux Y, Truffinet P, Aubeneau M, Kirkesseli S, Montay G. 1997. Single- and multiple-dose pharmacokinetics of riluzole in white subjects. J Clin Pharmacol 37:820-827.
30. Louvel E, Hugon J, Doble A. 1997. Therapeutic advances in amyotrophic lateral sclerosis. Trends Pharmacol Sci 18:196-203.
31. Monyer H, Seeburg PH, Wisden W. 1991. Glutamate-operated channels: developmentally early and mature forms arise by alternative splicing. Neuron 6:799-810.
32. Mosbacher J, Schoepfer R, Monyer H, Burnashev N, Seeburg PH, Ruppersberg JP. 1994. A molecular determinant for submillisecond desensitization in glutamate receptors. Science 266:1059-1062.
33. Paternain AV, Morales M, Lerina J. 1995. Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons. Neuron 14:185-189.
34. Peluffo H, Estevez A, Barbeito L, Stutzmann JM. 1997. Riluzole promotes survival of rat motoneurons in vitro by stimulating trophic activity produced by spinal astrocyte monolayers. Neurosci Lett 228:207-211.
35. Pieri M, Gaetti C, Spalloni A, Cavalcanti S, Mercuri N, Bernardi G, Longone P, Zona C. 2003a. alpha-Amino-3-hydroxy-5-methyl-isoxazole-4-propionate receptors in spinal cord motor neurons are altered in transgenic mice overexpressing human Cu,Zn Superoxide dismutase (Gly93→Ala) mutation. Neuroscience 122:47-58.
36. Pieri M, Albo F, Gaetti C, Spalloni A, Bengtson CP, Longone P, Cavalcanti S, Zona C. 2003b. Altered excitability of motor neurons in a transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci Lett 351:153-156.
37. Rosas HD, Koroshetz WJ, Jenkins BG, Chen YI, Hayden DL, Heal MF, Cudkowicz ME. 1999. Riluzole therapy in Huntington's disease (HD). Mov Disord 14:326-330.
38. Rothstein JD. 1995. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. Clin Neurosci 3:348-359.
39. Shibata T, Watanabe M, Ichikawa R, Inoue Y, Koyanagi T. 1999. Different expression of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid and N-methyl-D-aspartate receptor subunit mRNAs between visceromotor and somatomotor neurons of the rat lumbosacral spinal cord. J Comp Neurol 404:172-182.
40. Siniscalchi A, Zona C, Sancesario G, D'Angelo E, Zeng YC, Mercuri NB, Bernardi G. 1999. Neuroprotective effects of riluzole: an electrophysiological and histological analysis in an in vitro model of ischemia. Synapse 32:147-152.
41. Spalloni A, Albo F, Ferrari F, Mercuri N, Bernardi G, Zona C, Longone P. 2004. Cu/Zn-superoxide dismutase (GLY93→ALA) mutation alters AMPA receptor subunit expression and function and potentiates kainate-mediated toxicity in motor neurons in culture. Neurobiol Dis 15:340-350.
42. Takahashi T. 1990. Membrane currents in visually identified motoneurones of neonatal rat spinal cord. J Physiol 423:27-46.
43. Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. 2003. An outcome study of riluzole in amyotrophic lateral sclerosis-a population-based study in Ireland, 1996-2000. J Neurol 250:473-479.
44. Urbani A, Belluzzi O. 2000. Riluzole inhibits the persistent sodium current in mammalian CNS neurons. Eur J Neurosci 12:3567-3574.
45. Vandenberghe W, Ihle EC, Patneau DK, Robberecht W, Brorson JR. 2000. AMPA receptor current density not desensitization predicts selective motoneuron vulnerability. J Neurosci 20:7158-7166.
46. Van Den Bosch L, Vandenberghe W, Klaassen H, Van Houtte E, Robberecht W. 2000. Ca(2+)-permeable AMPA receptors and selective vulnerability of motor neurons. J Neurol Sci 180:29-34.
47. Xu L, Enyeart JA, Enyeart JJ. 2001. Neuroprotective agent riluzole dramatically slows inactivation of Kv 1.4 potassium channels by a voltage-dependent oxidative mechanism. J Pharmacol Exp Ther 299:227-237.
48. Zona C, Cavalcanti S, De Sarro G, Siniscalchi A, Marchetti C, Gaetti C, Costa N, Mercuri N, Bernardi C. 2002. Kainate-induced currents in rat cortical neurons in culture are modulated by riluzole. Synapse 43:244-251.
49. Zona C, Siniscalchi A, Mercuri NB, Bernardi G. 1998. Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons. Neuroscience 85:931-938.